#biologics

1 story

#car-t therapy #glp-1 #oncology #saroglitazar #specialty medicines #us generics #zydus lifesciences

Zydus Targets New Growth Areas
Zydus Lifesciences plans to expand into specialty medicines and biologics while maintaining US generics.
The Economic Times · 1m